MiniMed Group (MMED)

MiniMed Group on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

20.7M

Short interest

settlement 2026-10-15

1.0

Days to cover

-4.9 days vs prior

24.4%

Short share of volume

2026-10-28

61,031

Fails to deliver

settlement 2026-09-30

Wed 2 Jun

Next earnings

estimated date

Insider flow, 90 days

0 buys, 0 sells

As of 2026-10-28.

Short interest

FINRA, twice a month. The newest 15 settlements in the table, 15 in the chart. JSON

As of 15 October 2026, short interest in MMED is 20,704,820 shares, up 7,109,898 shares over the last month. Over the last 15 readings it ranged from 1,341,393 shares (13 March 2026) to 20,704,820 shares (15 October 2026). The latest reading sits at the top of that range. At the reported average volume of 23.1M shares a day that is 1.0 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/mmed" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-10-15	20,704,820	+13.8%	23,116,073	1.00
2026-09-30	18,197,982	+33.9%	3,090,662	5.89
2026-09-15	13,594,922	+68.7%	2,805,245	4.85
2026-08-31	8,060,409	+36.7%	1,382,055	5.83
2026-08-14	5,896,696	-2.1%	1,028,278	5.73
2026-07-31	6,026,212	-5.0%	1,268,374	4.75
2026-07-15	6,345,677	-3.4%	843,381	7.52
2026-06-30	6,570,728	+43.9%	1,516,105	4.33
2026-06-15	4,564,938	+13.0%	1,123,747	4.06
2026-05-29	4,041,105	-5.5%	636,778	6.35
2026-05-15	4,275,640	+17.0%	595,292	7.18
2026-04-30	3,655,603	+28.0%	754,271	4.85
2026-04-15	2,855,987	+3.8%	979,100	2.92
2026-03-31	2,751,000	+105.1%	789,593	3.48
2026-03-13	1,341,393	+100.0%	1,668,570	1.00

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 28 October 2026, the short share of MMED volume is 24.4%, up 6.6 points over the last five sessions. Over the last 30 readings it ranged from 17.9% (21 October 2026) to 89.9% (30 September 2026). The latest reading sits at the bottom of that range. The latest reading is 30.4 points below the 30-session average of 54.9%, on 4.3M shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-10-28	1.0M	4.3M	24.4%	6,000
2026-10-27	938K	3.2M	29.5%	0
2026-10-26	534K	2.0M	26.4%	0
2026-10-23	770K	2.0M	38.9%	0
2026-10-22	1.4M	4.0M	35.5%	0
2026-10-21	934K	5.2M	17.9%	0
2026-10-20	1.3M	4.1M	30.8%	0
2026-10-19	1.2M	4.2M	28.6%	0
2026-10-16	2.4M	6.0M	40.0%	0
2026-10-15	2.4M	8.5M	28.2%	39,914
2026-10-14	5.1M	12.1M	42.3%	880
2026-10-13	2.5M	6.3M	39.4%	12
2026-10-12	8.1M	11.7M	69.5%	1,500
2026-10-09	5.9M	7.4M	78.7%	0
2026-10-08	6.3M	8.6M	73.2%	0
2026-10-07	2.5M	4.0M	62.2%	0
2026-10-06	2.5M	4.1M	60.4%	110
2026-10-05	3.2M	5.0M	64.9%	15,145
2026-10-02	1.2M	1.7M	70.4%	0
2026-10-01	1.3M	1.7M	75.9%	0
2026-09-30	1.5M	1.6M	89.9%	0
2026-09-29	672K	930K	72.3%	911
2026-09-28	1.1M	1.4M	78.7%	0
2026-09-25	746K	1.1M	71.0%	200
2026-09-24	982K	1.4M	72.5%	4,802
2026-09-23	941K	1.3M	71.5%	0
2026-09-22	813K	1.3M	60.9%	0
2026-09-21	612K	1.0M	61.0%	0
2026-09-18	348K	624K	55.8%	0
2026-09-17	933K	1.2M	74.8%	8

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 30 September 2026, the fails-to-deliver balance in MMED is 61,031 shares, up 31,714 shares over the last settlement date. Over the last 30 readings it ranged from 493 shares (25 September 2026) to 324,794 shares (19 August 2026).

Settlement	Shares failed	Price	Value
2026-09-30	61,031	$20.04	$1.2M
2026-09-28	29,317	$19.98	$586K
2026-09-25	493	$20.44	$10K
2026-09-24	1,471	$20.54	$30K
2026-09-23	998	$21.20	$21K
2026-09-22	51,137	$21.12	$1.1M
2026-09-21	27,624	$21.79	$602K
2026-09-18	13,193	$22.03	$291K
2026-09-17	11,143	$22.40	$250K
2026-09-16	1,385	$22.01	$30K
2026-09-15	24,212	$21.97	$532K
2026-09-11	95,927	$22.44	$2.2M
2026-09-10	139,332	$22.76	$3.2M
2026-09-09	44,949	$23.32	$1.0M
2026-09-08	109,194	$23.29	$2.5M
2026-09-04	5,298	$23.84	$126K
2026-09-03	10,231	$23.76	$243K
2026-09-02	106,961	$22.42	$2.4M
2026-09-01	67,644	$20.26	$1.4M
2026-08-31	14,134	$20.10	$284K
2026-08-28	148,831	$19.51	$2.9M
2026-08-27	8,309	$19.49	$162K
2026-08-26	36,145	$18.92	$684K
2026-08-24	1,865	$20.45	$38K
2026-08-21	78,136	$20.18	$1.6M
2026-08-20	77,500	$20.22	$1.6M
2026-08-19	324,794	$19.36	$6.3M
2026-08-18	153,911	$19.53	$3.0M
2026-08-17	17,900	$20.15	$361K
2026-08-14	6,485	$20.02	$130K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for MMED in the last 90 days. The most recent filings are listed below. Latest filing: Chandrasena Gillian (SVP, Chief HR Officer) on 2026-10-15.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-10-15	Chandrasena Gillian	SVP, Chief HR Officer	Grant	2K	price not stated in the filing	not stated	175K
2026-10-15	Dianaty Ali	EVP Ch. Prod. & Tech Officer	Grant	11K	price not stated in the filing	not stated	326K
2026-10-15	Lofton Kevin E	Director	Grant	836	price not stated in the filing	not stated	40K
2026-10-15	Medtronic plc	10% owner	Other transaction	252.8M	price not stated in the filing	not stated	0
2026-10-15	Endicott David J.	Director	Grant	3K	$0.00	$0	15K
2026-10-15	Bricker Amy	Director	Grant	12K	$0.00	$0	12K
2026-10-15	Hopkins Robert (Bob)	Director	Grant	12K	$0.00	$0	12K
2026-10-09	EISENBERG GLENN A	Director	Grant	12K	$0.00	$0	26K
2026-10-09	Endicott David J.	Director	Grant	12K	$0.00	$0	12K
2026-10-09	GROSSMAN D KEITH	Director	Grant	12K	$0.00	$0	26K
2026-10-09	Lofton Kevin E	Director	Grant	12K	$0.00	$0	40K
2026-10-09	Wicks Timothy A	Director	Grant	12K	$0.00	$0	26K
2026-10-01	Denton Sheila A.	SVP, Gen. Counsel & Corp. Sec.	Grant	59K	$0.00	$0	59K
2026-07-31	Wills Courtney Nelson	SVP, Gen. Counsel, Corp. Sec.	Tax withholding	2K	$18.15	$32K	136K
2026-07-31	Dianaty Ali	EVP Ch. Prod. & Tech Officer	Tax withholding	8K	$18.15	$145K	315K
2026-07-31	Dallara Que	Chief Executive Officer	Tax withholding	31K	$18.15	$569K	885K
2026-07-28	Spooner Chad	EVP, Chief Financial Officer	Tax withholding	23K	$17.67	$412K	363K
2026-07-28	Chandrasena Gillian	SVP, Chief HR Officer	Tax withholding	2K	$17.67	$37K	173K
2026-07-01	Spooner Chad	EVP, Chief Financial Officer	Grant	22K	$0.00	$0	386K
2026-07-01	Spooner Chad	EVP, Chief Financial Officer	Grant	95K	$0.00	$0	364K
2026-07-01	Wills Courtney Nelson	SVP, Gen. Counsel, Corp. Sec.	Grant	22K	$0.00	$0	138K
2026-07-01	Wills Courtney Nelson	SVP, Gen. Counsel, Corp. Sec.	Grant	61K	$0.00	$0	116K
2026-07-01	Gyurci John	VP, Chief Accounting Officer	Grant	24K	$0.00	$0	40K
2026-07-01	Dianaty Ali	See Remarks	Grant	37K	$0.00	$0	323K
2026-07-01	Dianaty Ali	See Remarks	Grant	95K	$0.00	$0	286K
2026-07-01	Dallara Que	Chief Executive Officer	Grant	298K	$0.00	$0	916K
2026-07-01	Chandrasena Gillian	SVP, Chief HR Officer	Grant	15K	$0.00	$0	175K
2026-07-01	Chandrasena Gillian	SVP, Chief HR Officer	Grant	29K	$0.00	$0	160K
2026-03-25	Dallara Que	Chief Executive Officer	Tax withholding	5K	$16.31	$78K	617K
2026-03-11	Chandrasena Gillian	See Remarks	Grant	11K	price not stated in the filing	not stated	11K
2026-03-11	Dianaty Ali	See Remarks	Grant	35K	price not stated in the filing	not stated	35K
2026-03-11	Spooner Chad	EVP, Chief Financial Officer	Grant	71K	price not stated in the filing	not stated	71K
2026-03-11	Dallara Que	Chief Executive Officer	Grant	23K	price not stated in the filing	not stated	23K
2026-03-11	Dallara Que	Chief Executive Officer	Grant	282K	price not stated in the filing	not stated	282K
2026-03-11	Dallara Que	Chief Executive Officer	Grant	128K	price not stated in the filing	not stated	128K
2026-03-11	Dallara Que	Chief Executive Officer	Grant	57K	price not stated in the filing	not stated	57K
2026-03-11	Dallara Que	Chief Executive Officer	Grant	51K	price not stated in the filing	not stated	51K
2026-03-11	Dallara Que	Chief Executive Officer	Grant	81K	price not stated in the filing	not stated	81K
2026-03-11	Spooner Chad	EVP, Chief Financial Officer	Grant	128K	price not stated in the filing	not stated	128K
2026-03-11	Spooner Chad	EVP, Chief Financial Officer	Grant	71K	price not stated in the filing	not stated	71K
2026-03-11	Dianaty Ali	See Remarks	Grant	2K	price not stated in the filing	not stated	2K
2026-03-11	Dianaty Ali	See Remarks	Grant	12K	price not stated in the filing	not stated	12K
2026-03-11	Dianaty Ali	See Remarks	Grant	34K	price not stated in the filing	not stated	34K
2026-03-11	Dianaty Ali	See Remarks	Grant	15K	price not stated in the filing	not stated	15K
2026-03-11	Dianaty Ali	See Remarks	Grant	35K	price not stated in the filing	not stated	35K
2026-03-11	Dianaty Ali	See Remarks	Grant	47K	price not stated in the filing	not stated	47K
2026-03-11	Dianaty Ali	See Remarks	Grant	11K	price not stated in the filing	not stated	11K
2026-03-11	Wills Courtney Nelson	See Remarks	Grant	6K	price not stated in the filing	not stated	6K
2026-03-11	Wills Courtney Nelson	See Remarks	Grant	18K	price not stated in the filing	not stated	18K
2026-03-11	Wills Courtney Nelson	See Remarks	Grant	14K	price not stated in the filing	not stated	14K
2026-03-11	Wills Courtney Nelson	See Remarks	Grant	955	price not stated in the filing	not stated	955
2026-03-11	Wills Courtney Nelson	See Remarks	Grant	11K	price not stated in the filing	not stated	11K
2026-03-11	Wills Courtney Nelson	See Remarks	Grant	5K	price not stated in the filing	not stated	5K
2026-03-11	Chandrasena Gillian	See Remarks	Grant	59K	price not stated in the filing	not stated	59K
2026-03-11	Chandrasena Gillian	See Remarks	Grant	28K	price not stated in the filing	not stated	28K
2026-03-11	Chandrasena Gillian	See Remarks	Grant	20K	price not stated in the filing	not stated	20K
2026-03-11	Chandrasena Gillian	See Remarks	Grant	11K	price not stated in the filing	not stated	11K
2026-03-11	Gyurci John	See Remarks	Grant	15K	price not stated in the filing	not stated	15K
2026-03-09	Wicks Timothy A	Director	Grant	14K	$0.00	$0	14K
2026-03-09	Lofton Kevin E	Director	Grant	28K	$0.00	$0	28K
2026-03-09	GROSSMAN D KEITH	Director	Grant	14K	$0.00	$0	14K
2026-03-09	EISENBERG GLENN A	Director	Grant	14K	$0.00	$0	14K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

5 holders report 5% or more of MMED in their latest filing, all on Schedule 13G (passive). The largest reported stake is Susquehanna Securities, LLC at 7.8% of the class (21,911,680 shares), filed 2026-10-22 for an event on 2026-10-15.

Filed	Form	Holder	Shares	Of class	Event
2026-10-22	13G	Susquehanna Securities, LLCbroker-dealer, other entity	21.9M	7.8%	2026-10-15
2026-10-22	13G	Susquehanna Portfolio Strategies, LLCother entity	21.9M	7.8%	2026-10-15
2026-10-22	13G	Susquehanna Fundamental Investments, LLCother entity	21.9M	7.8%	2026-10-15
2026-10-22	13G	Susquehanna Advisors Group, Inc.corporation	21.9M	7.8%	2026-10-15
2026-10-22	13G	Capital Ventures Internationalcorporation	21.9M	7.8%	2026-10-15
2026-10-16	13G/Ano. 1	Medtronic plcnon-US institution	0	0.0%	2026-10-15

13F holders

Tracked managers holding MMED at their latest 13F. JSON

5 of the 30 tracked managers held MMED at their latest 13F, $90.8M in total at quarter-end prices. Millennium Management is the largest at $45.8M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 1 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
Millennium Management	2026-06-30	3.1M	$45.8M	0.02%	+467K
Citadel Advisors	2026-06-30	2.9M	$42.8M	0.00%	+14K
Renaissance Technologies	2026-06-30	88K	$1.3M	0.00%	new
Two Sigma Investments	2026-06-30	41K	$607K	0.00%	+24K
Point72 Asset Management	2026-06-30	15K	$230K	0.00%	-1.1M

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

MiniMed Group in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows MiniMed Group (MMED), SEC CIK 2062583, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-28.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-30.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-22.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-09-01.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-15.JSON and CSV
Company record: EDGAR filing index for CIK 2062583Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of MMED is sold short?

20,704,820 shares were held short at the 2026-10-15 settlement, 1.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is MMED's daily short volume?

On 2026-10-28, 1,043,135 of the 4,271,518 MMED shares reported to FINRA were sold short, 24.4% of the day's reported volume. Short volume is a flow for one day, not a position.

Does MMED have fails to deliver?

The SEC's latest file shows 61,031 MMED shares failed to deliver at settlement 2026-09-30. Fails are reported per settlement date and published twice a month with a lag.

Are MMED insiders buying or selling?

No open-market insider trades were reported for MMED in the last 90 days. The most recent filings are listed below. Latest filing: Chandrasena Gillian (SVP, Chief HR Officer) on 2026-10-15.

Who owns 5% or more of MMED?

Which tracked 13F managers own MMED?

5 of the 30 tracked 13F managers held MMED shares at their latest filing, $90.8M in all. The largest: Izzy Englander's Millennium Management (3.1M shares, $45.8M), Ken Griffin's Citadel Advisors (2.9M shares, $42.8M), Renaissance Technologies (88K shares, $1.3M), Two Sigma Investments (41K shares, $607K), Steve Cohen's Point72 Asset Management (15K shares, $230K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.

MiniMed Group (MMED)

Short interest

Daily short volume

Fails to deliver

Insider trades

Large holders (13D and 13G)

13F holders

MiniMed Group in the regulatory record

Source and updates

How to read it

Other company pages

Datasets

Frequently Asked Questions